Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Bond

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Hematology|July 28, 2022
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective studyMegan Fleming, Ying Huang, Emily Dotson, et al.
Leukemia & Lymphoma|February 7, 2022
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphomaDavid A Bond, Ying Huang, Beth A Christian, et al.
Blood Advances|November 17, 2021
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomasMegan Fleming, Ying Huang, Emily Dotson, et al.
Haematologica|May 25, 2023
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphomaMax J Gordon, David A Bond, Adam S Kittai, et al.
Blood Neoplasia|May 7, 2026
Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemiaJohn Sharp, Subodh Bhatta, Noah Takacs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone LymphomaJohn Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
American Journal of Hematology|October 10, 2022
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinibAdam S Kittai, Ying Huang, Kyle A Beckwith, et al.
Journal of Hematology & Oncology|January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphomaSayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Hematology|July 28, 2022
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective studyMegan Fleming, Ying Huang, Emily Dotson, et al.
Leukemia & Lymphoma|February 7, 2022
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphomaDavid A Bond, Ying Huang, Beth A Christian, et al.
Blood Advances|November 17, 2021
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomasMegan Fleming, Ying Huang, Emily Dotson, et al.
Haematologica|May 25, 2023
TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphomaMax J Gordon, David A Bond, Adam S Kittai, et al.
Blood Neoplasia|May 7, 2026
Impact of baseline osseous involvement on outcomes in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemiaJohn Sharp, Subodh Bhatta, Noah Takacs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone LymphomaJohn Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
American Journal of Hematology|October 10, 2022
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinibAdam S Kittai, Ying Huang, Kyle A Beckwith, et al.
Journal of Hematology & Oncology|January 5, 2025
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphomaSayan Mullick Chowdhury, Subodh Bhatta, Timothy J Voorhees, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Pageof 6